• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定潜在的PPARγ激动剂作为降血糖药物:分子对接方法。

Identification of Potential PPAR γ Agonists as Hypoglycemic Agents: Molecular Docking Approach.

作者信息

Mishra Ganesh Prasad, Sharma Rajesh

机构信息

School of Pharmacy, Devi Ahilya Vishwavidyalaya, Takshshila Campus, Khandwa Road, Indore, M.P., 452 001, India.

出版信息

Interdiscip Sci. 2016 Sep;8(3):220-8. doi: 10.1007/s12539-015-0126-7. Epub 2015 Sep 15.

DOI:10.1007/s12539-015-0126-7
PMID:26374652
Abstract

Peroxisome proliferator-activated receptor gamma (PPAR γ) has become an attractive molecular target for drugs that aim to treat hyperglycemia. The object of our study is to identify the required molecular descriptor and essential amino acid residues for effective PPAR γ agonistic activity. In this work, we employed Molegro Virtual Docker program in all molecular docking simulations. Accuracy of receptor-compound docking was validated on a set of 15 PPAR γ-compound complexes for which crystallographic structures were available. The reliability of the docking results was acceptable with good root-mean-square deviation value (<2 Å). A significant correlation between different data derived from docking calculations and experimental data was revealed. Our results allowed identification of compounds with potential to become drugs against hyperglycemia.

摘要

过氧化物酶体增殖物激活受体γ(PPARγ)已成为旨在治疗高血糖的药物的一个有吸引力的分子靶点。我们研究的目的是确定有效PPARγ激动活性所需的分子描述符和必需氨基酸残基。在这项工作中,我们在所有分子对接模拟中使用了Molegro Virtual Docker程序。在一组15个具有晶体结构的PPARγ-化合物复合物上验证了受体-化合物对接的准确性。对接结果的可靠性是可以接受的,均方根偏差值良好(<2 Å)。揭示了对接计算得出的不同数据与实验数据之间的显著相关性。我们的结果有助于鉴定具有成为抗高血糖药物潜力的化合物。

相似文献

1
Identification of Potential PPAR γ Agonists as Hypoglycemic Agents: Molecular Docking Approach.鉴定潜在的PPARγ激动剂作为降血糖药物:分子对接方法。
Interdiscip Sci. 2016 Sep;8(3):220-8. doi: 10.1007/s12539-015-0126-7. Epub 2015 Sep 15.
2
Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -α/γ dual agonists for treatment of metabolic disorders.基于结构的对接和分子动力学研究:过氧化物酶体增殖物激活受体-α/γ双重激动剂治疗代谢紊乱。
J Biomol Struct Dyn. 2020 Feb;38(2):511-523. doi: 10.1080/07391102.2019.1581089. Epub 2019 Mar 11.
3
Identification of novel PPARα/γ dual agonists by pharmacophore screening, docking analysis, ADMET prediction and molecular dynamics simulations.通过药效基团筛选、对接分析、ADMET 预测和分子动力学模拟鉴定新型 PPARα/γ 双重激动剂。
Comput Biol Chem. 2019 Feb;78:178-189. doi: 10.1016/j.compbiolchem.2018.11.023. Epub 2018 Nov 27.
4
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.来自传统中药的 PPAR-α、PPAR-γ 和 PPAR-δ 的三一体激动剂。
J Biomol Struct Dyn. 2012;30(6):662-83. doi: 10.1080/07391102.2012.689699. Epub 2012 Jun 26.
5
Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.发现噻唑烷-2,4-二酮/联苯甲腈杂合体具有抗糖尿病作用的双重 PPARα/γ调节剂:体外、计算和体内方法。
Chem Biol Drug Des. 2013 Apr;81(4):474-83. doi: 10.1111/cbdd.12102. Epub 2013 Mar 21.
6
Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones.一些 PPAR-γ 激动剂的合理设计与合成:取代的亚苄基氨基-亚苄基-噻唑烷-2,4-二酮。
Comput Biol Chem. 2017 Apr;67:260-265. doi: 10.1016/j.compbiolchem.2017.02.004. Epub 2017 Feb 7.
7
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.通过核心跳跃法设计新型双重激动剂,以过氧化物酶体增殖物激活受体为靶点治疗 2 型糖尿病。
PLoS One. 2012;7(6):e38546. doi: 10.1371/journal.pone.0038546. Epub 2012 Jun 7.
8
Design, development and evaluation of novel dual PPARδ/PPARγ agonists.新型双重 PPARδ/PPARγ 激动剂的设计、开发与评估。
Bioorg Med Chem Lett. 2013 Feb 1;23(3):873-9. doi: 10.1016/j.bmcl.2012.11.060. Epub 2012 Dec 3.
9
Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.噻唑烷-2,4-二酮衍生物作为 PPAR-γ 激动剂:合成、分子对接、体外和体内抗糖尿病活性及肝毒性风险评估和对 PPAR-γ 基因表达的影响。
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3034-42. doi: 10.1016/j.bmcl.2014.05.034. Epub 2014 May 22.
10
Development of docking-based 3D-QSAR models for PPARgamma full agonists.基于对接的 PPARγ 全激动剂 3D-QSAR 模型的开发。
J Mol Graph Model. 2012 Jun;36:1-9. doi: 10.1016/j.jmgm.2012.03.001. Epub 2012 Mar 14.

引用本文的文献

1
An evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer.对洛拉替尼作为一种潜在疗法用于治疗与癌症相关的间变性淋巴瘤激酶(ALK)蛋白酪氨酸激酶结构域中新型氨基酸替代的评估。
Front Pharmacol. 2025 Jun 18;16:1605314. doi: 10.3389/fphar.2025.1605314. eCollection 2025.
2
Molecular insights and inhibitory dynamics of flavonoids in targeting Pim-1 kinase for cancer therapy.黄酮类化合物靶向Pim-1激酶用于癌症治疗的分子见解与抑制动力学
Front Pharmacol. 2024 Oct 7;15:1440958. doi: 10.3389/fphar.2024.1440958. eCollection 2024.
3
A Combined Molecular Dynamics and Hydropathic INTeraction (HINT) Approach to Investigate Protein Flexibility: The PPARγ Case Study.
一种结合分子动力学和疏水力相互作用(HINT)的方法来研究蛋白质柔性:以 PPARγ 为例。
Molecules. 2024 May 10;29(10):2234. doi: 10.3390/molecules29102234.
4
An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration.一些新型螺环-N-(4-氨磺酰基苯基)-1,3,4-噻二唑-2-甲酰胺衍生物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶潜在抑制剂的高效、环保、简单且绿色的合成:类药性、药效团、分子对接及密度泛函理论研究
Mol Divers. 2024 Feb;28(1):249-270. doi: 10.1007/s11030-023-10761-0. Epub 2023 Nov 9.
5
Synergistic Promotion on Tyrosinase Inhibition by Antioxidants.抗氧化剂对酪氨酸酶抑制的协同促进作用。
Molecules. 2018 Jan 4;23(1):106. doi: 10.3390/molecules23010106.